398
Participants
Start Date
June 7, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
June 30, 2027
ASP2138
Intravenously or Subcutaneously
Pembrolizumab
Intravenously
Oxaliplatin
Intravenously
Leucovorin
Intravenously
Fluorouracil
Intravenously
Ramucirumab
Intravenously
Paclitaxel
Intravenously
Irinotecan
Intravenously
Capecitabine
Oral Administration
RECRUITING
NYU Langone Medical Center - NYU Medical Oncology Associates, New York
RECRUITING
Columbia University, New York
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Wake Forest University Baptist Health, Winston-Salem
RECRUITING
Duke Children's Hospital and Health Center, Durham
RECRUITING
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
RECRUITING
Northwestern University, Chicago
RECRUITING
University of Kansas Cancer Center, Westwood
RECRUITING
UT Southwestern Medical Center, Dallas
WITHDRAWN
UCLA Dept of Medicine - Hematology/Oncology, Santa Monica, Santa Monica
RECRUITING
University of California Irvine Medical Center, Orange
RECRUITING
Virginia Mason Medical Center, Seattle
COMPLETED
Rutgers Cancer Institute of New Jersey, New Brunswick
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan
RECRUITING
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
RECRUITING
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou
RECRUITING
Site FR33005, Vaillant
RECRUITING
Site FR33003, Lyon
RECRUITING
Site FR33004, Marseille
RECRUITING
Site FR33006, Poitiers
RECRUITING
Site FR33001, Saint-Herblain
RECRUITING
Site FR33002, Toulouse
RECRUITING
Site IT39004, Milan
RECRUITING
Site IT39001, Milan
RECRUITING
Site IT39005, Rozzano
RECRUITING
Site IT39003, Verona
RECRUITING
Aichi Cancer Center, Nagoya
RECRUITING
National Cancer Center Hospital East, Kashiwa
RECRUITING
Kanagawa Cancer Center, Yokohama
RECRUITING
Kindai University Hospital, Sayama
RECRUITING
The University of Osaka Hospital, Suita
RECRUITING
National Cancer Center Hospital, Chuo-ku
RECRUITING
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku
RECRUITING
Site PR16101, San Juan
RECRUITING
Site KR82004, Seongnam-si
RECRUITING
Site KR82001, Guro-gu
RECRUITING
Site KR82002, Jongno-gu
RECRUITING
Site KR82003, Seocho-gu
RECRUITING
Site KR82005, Seodaemun-gu
RECRUITING
Site ES34002, Barcelona
RECRUITING
Site ES34007, El Palmar
Astellas Pharma Global Development, Inc.
INDUSTRY